赛诺菲安万特 SNY 深 沪
等待开盘 08-10 09:30:00 美东时间
43.46
+0.570
+1.33%
华盛通- 最 高43.865
- 今 开43.57
- 成交量 275.66万股
- 最 低 42.54
- 昨 收 42.89
- 总市值 1.10亿
- 52周最高 52.68
- 市盈率 静 14.86
- 换手率 109.09%
- 52周最低 40.89
- 委 比 -91.04%
- 总股本 0.03亿
- 历史最高 60.115
- 量 比 0.59
- 振 幅 3.09%
- 历史最低 1.10
- 每 手 1
- 风险率 2.62%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Sanofi Drops Dupixent Successor Candidate After Assessing Data
Sanofi discontinued amlitelimab for atopic dermatitis after reviewing phase 3 efficacy and safety data, ending plans for regulatory filings.
07-25 02:10
Sanofi's Subcutaneous Sarclisa Escena Receives FDA Approval To Treat Multiple Myeloma
The US Food and Drug Administration (FDA) has approved subcutaneous (SC) Sarclisa (isatuximab-irfc) Escena in combination with standard-of-care regimens for the treatment of patients with multiple myeloma (MM) across
07-10 20:55
Sino Biopharma Accelerates Global Growth With GSK, AstraZeneca Partnerships
Sino Biopharma expanded its GSK partnership in China and signed an AstraZeneca licensing deal worth up to $2.1 billion.
07-08 22:14
EU Launches Antitrust Probe Into Sanofi Over Allegedly Misleading Flu Vaccine Claims (UPDATED)
EU opens antitrust probe into Sanofi over claims it disparaged rival flu vaccine Fluad in Germany and France.
06-29 23:44
Europe Approves Sanofi's Multiple Sclerosis Drug Despite FDA Rejection
Sanofi won European approval for Cenrifki in SPMS and secured Japan authorization for Wayrilz in chronic ITP.
06-24 00:21
AbbVie Expands Immunology Footprint With Apogee $11 Billion Acquisition
AbbVie will acquire Apogee for $10.9 billion, adding late-stage immunology and asthma assets to its pipeline.
06-22 21:15
FDA OKs Sanofi Diabetes Drug In Newly Diagnosed Pediatric Patients
FDA grants accelerated approval to Sanofi Tzield for children with newly diagnosed stage 3 type 1 diabetes, backed by Phase 3 data.
06-16 01:15
Sanofi Trial Setback May Reinforce Argenx Vyvgart's Position: Analyst
Sanofi discontinues Phase 3 riliprubart study for CIDP due to low efficacy. SNY stock ticks up. Read the market & analyst reaction.
06-11 21:09
Sanofi-Owkin Expand AI Collaboration With New Agentic AI Initiative
Owkin and Sanofi expand their AI partnership with a five-year deal to develop agentic systems aimed at accelerating drug research.
06-05 19:01
Regeneron Flags FDA Delays For Eylea HD Prefilled Syringe
Regeneron beats Q1 estimates as Eylea HD demand rises, while margins narrow and FDA decisions on manufacturing remain pending.
04-30 01:57
